Eligibility and prescribing rates of SGLT2 inhibitors for patients with heart failure from a large tertiary centre

Nadarajah, R orcid.org/0000-0001-9895-9356, Younis, A, Aktaa, S orcid.org/0000-0002-9854-481X et al. (1 more author) (2021) Eligibility and prescribing rates of SGLT2 inhibitors for patients with heart failure from a large tertiary centre. In: Heart Failure 2021 and the World Congress on Acute Heart Failure, 29 Jun - 01 Jul 2021, Online.

Metadata

Authors/Creators:
Dates:
  • Published: September 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Clinical & Population Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Sep 2022 09:40
Last Modified: 06 Sep 2022 09:40
Status: Published
Identification Number: https://doi.org/10.1002/ejhf.2297
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)